ReShape stock gains on all-stock merger deal (NASDAQ:RSLS)
Maksim Labkouski Shares of ReShape Lifesciences (NASDAQ:RSLS) climbed in the premarket Tuesday after the medical device maker reached a merger agreement to combine with privately held specialty pharma company Vyome Therapeutics in an all-stock transaction. Per the terms of the deal, current ReShape (RSLS) stockholders will own a roughly 11.1%Continue Reading